Utilization and survival outcomes of sequential, concurrent and sandwich therapies for advanced stage endometrial cancers by histology
EM Ko, CM Brensinger, L Cory, RL Giuntoli 2nd… - Gynecologic …, 2020 - Elsevier
Objective To determine the impact on overall survival (OS) of different modalities of adjuvant
therapy for the treatment of stage III endometrial cancer (EC), by histology. Methods Stage 3 …
therapy for the treatment of stage III endometrial cancer (EC), by histology. Methods Stage 3 …
Utilization and survival outcomes of sequential, concurrent and sandwich therapies for advanced stage endometrial cancers by histology.
EM Ko, CM Brensinger, L Cory… - Gynecologic …, 2020 - europepmc.org
Objective To determine the impact on overall survival (OS) of different modalities of adjuvant
therapy for the treatment of stage III endometrial cancer (EC), by histology. Methods Stage 3 …
therapy for the treatment of stage III endometrial cancer (EC), by histology. Methods Stage 3 …
Utilization and survival outcomes of sequential, concurrent and sandwich therapies for advanced stage endometrial cancers by histology
EM Ko, CM Brensinger, L Cory… - Gynecologic …, 2020 - pubmed.ncbi.nlm.nih.gov
Objective To determine the impact on overall survival (OS) of different modalities of adjuvant
therapy for the treatment of stage III endometrial cancer (EC), by histology. Methods Stage 3 …
therapy for the treatment of stage III endometrial cancer (EC), by histology. Methods Stage 3 …
Utilization and survival outcomes of sequential, concurrent and sandwich therapies for advanced stage endometrial cancers by histology
EM Ko, CM Brensinger, L Cory… - Gynecologic …, 2020 - gynecologiconcology-online.net
Objective To determine the impact on overall survival (OS) of different modalities of adjuvant
therapy for the treatment of stage III endometrial cancer (EC), by histology. Methods Stage 3 …
therapy for the treatment of stage III endometrial cancer (EC), by histology. Methods Stage 3 …
Utilization and survival outcomes of sequential, concurrent and sandwich therapies for advanced stage endometrial cancers by histology
EM Ko, CM Brensinger, L Cory… - Gynecologic …, 2020 - mdanderson.elsevierpure.com
Objective: To determine the impact on overall survival (OS) of different modalities of adjuvant
therapy for the treatment of stage III endometrial cancer (EC), by histology. Methods: Stage 3 …
therapy for the treatment of stage III endometrial cancer (EC), by histology. Methods: Stage 3 …
Utilization and survival outcomes of sequential, concurrent and sandwich therapies for advanced stage endometrial cancers by histology
EM Ko, CM Brensinger, L Cory… - Gynecologic …, 2020 - gynecologiconcology-online.net
Objective To determine the impact on overall survival (OS) of different modalities of adjuvant
therapy for the treatment of stage III endometrial cancer (EC), by histology. Methods Stage 3 …
therapy for the treatment of stage III endometrial cancer (EC), by histology. Methods Stage 3 …